Dual TTK/PLK1 inhibition has potent anticancer activity in TNBC as monotherapy and in combination

Overview of attention for article published in Frontiers in oncology, August 2024

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 X post from an account with 6,541 followers.

New Research: Dual TTK/PLK1 inhibition has potent anticancer activity in TNBC as monotherapy and in combination https://t.co/vYPBd0tOp1 #FrontiersIn #Oncology

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.